Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing Derived Induced Pluripotent Stem Cells From Blood as a Model for the Study to Understand Imprinted Disorders

NCT05214742 is registered in ClinicalTrials.gov with Institute of Cardiometabolism and Nutrition, France as lead sponsor.

NCT NCT05214742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05214742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing Derived Induced Pluripotent Stem Cells From Blood as a Model for the Study to Understand Imprinted Disorders
Lead sponsor
Institute of Cardiometabolism and Nutrition, France
Phase
Observational
Overall status
Enrolling by invitation
Start date
January 19, 2022
Completion date
December 31, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

induced pluripotent stem cells